LON:ONC - Oncimmune Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 132.50 0.00 (0.00 %) (As of 09/23/2018 04:00 PM ET)Previous CloseGBX 132.50Today's RangeGBX 130 - GBX 132.9052-Week RangeGBX 100 - GBX 150Volume4,015 shsAverage Volume33,554 shsMarket Capitalization£85.08 millionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Oncimmune Holdings Plc, an early cancer detection company, develops and commercializes products to diagnose cancer in the United Kingdom and North America. The company engages in the development of autoantibody assay technologies to allow cancer detection to a range of solid cancer tumor types. It offers EarlyCDT-Lung, a blood test, which is ordered by a doctor to aid in the risk assessment and early detection of lung cancer in high-risk patients and to stratify indeterminate pulmonary nodules for the risk of malignancy. The company also develops EarlyCDT tests for liver and ovarian cancer. Oncimmune Holdings Plc was incorporated in 2015 and is based in Nottingham, the United Kingdom. Receive ONC News and Ratings via Email Sign-up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical SymbolLON:ONC CUSIPN/A Weboncimmune.com Phone+44-115-8231869 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-3,668.83% Return on Equity-95.26% Return on Assets-81.13% Miscellaneous EmployeesN/A Outstanding Shares54,380,000Market Cap£85.08 million Oncimmune (LON:ONC) Frequently Asked Questions What is Oncimmune's stock symbol? Oncimmune trades on the London Stock Exchange (LON) under the ticker symbol "ONC." How were Oncimmune's earnings last quarter? Oncimmune Holdings PLC (LON:ONC) issued its quarterly earnings results on Tuesday, February, 13th. The company reported ($5.70) EPS for the quarter. The business had revenue of $0.08 million for the quarter. Oncimmune had a negative return on equity of 95.26% and a negative net margin of 3,668.83%. View Oncimmune's Earnings History. What price target have analysts set for ONC? 2 equities research analysts have issued 1 year price objectives for Oncimmune's shares. Their forecasts range from GBX 168 to GBX 169. On average, they expect Oncimmune's share price to reach GBX 168.50 in the next twelve months. This suggests a possible upside of 27.2% from the stock's current price. View Analyst Price Targets for Oncimmune. What is the consensus analysts' recommendation for Oncimmune? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oncimmune in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Oncimmune. Who are some of Oncimmune's key competitors? Some companies that are related to Oncimmune include MaxCyte (MXCT), Palatin Technologies (PTN), EPIGENOMICS AG/S (EPGNY), Profound Medical (PRN), Lexagene (LXG), Sernova (SVA), Co-Diagnostics (CODX), SQI Diagnostics (SQD), Parallax Health Sciences (PRLX), Cambridge Cognition (COG), LED Medical Diagnostics (LMD), 3D Signatures (DXD), GeneNews (GEN), Deepmatter Group (DMTR) and Genedrive (GDR). Who are Oncimmune's key executives? Oncimmune's management team includes the folowing people: Mr. Geoffrey Hamilton-Fairley, CEO & DirectorMr. Andrew Millet BA, MBA, FCA, CFO, Company Sec. & Exec. Director (Age 50)Mr. Andrew Millet, CFO, Company Sec. & Exec. Director (Age 51)Dr. Laura J. Peek, Principal Scientist & Assistant Lab DirectorDr. Andrea Murray, Chief Operational Scientist How do I buy shares of Oncimmune? Shares of ONC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Oncimmune's stock price today? One share of ONC stock can currently be purchased for approximately GBX 132.50. How big of a company is Oncimmune? Oncimmune has a market capitalization of £85.08 million. What is Oncimmune's official website? The official website for Oncimmune is http://oncimmune.com/. How can I contact Oncimmune? Oncimmune's mailing address is Hucknall Road, NOTTINGHAM, NG5 1PB, United Kingdom. The company can be reached via phone at +44-115-8231869. MarketBeat Community Rating for Oncimmune (LON ONC)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 41 (Vote Outperform)Underperform Votes: 61 (Vote Underperform)Total Votes: 102MarketBeat's community ratings are surveys of what our community members think about Oncimmune and other stocks. Vote "Outperform" if you believe ONC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ONC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/23/2018 by MarketBeat.com StaffFeatured Article: What is the S&P 500 Index?